Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00978588

Enrollment

Registered

2009-09-17

Start date

2008-02-29

Completion date

2009-08-31

Last updated

2012-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mitral Valvular Heart Disease

Brief summary

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Interventions

DRUG6% hydroxyethyl starch 130/0.4 and 5% albumin

Injection of 6% hydroxyethyl starch 130/0.4 and 5% albumin as priming solution for cardiopulmonary bypass

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Healthy volunteers

Inclusion criteria

* Mitral valvular heart disease

Exclusion criteria

* Status of Infection * Re-operation * Liver failure * Renal disease * Administration of steroid

Design outcomes

Primary

Measure	Time frame
the pure effect of priming solutions	after CPB

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026